AlphaFold predicted structure
SLC45A2 · Q9UMX9

Mean pLDDT
77.8/ 100
Confident
530 residues
Confidence breakdown
- Very high(≥ 90)35%
- Confident(70–90)41%
- Low(50–70)8%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 45 member 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Albinism or congenital nystagmus
BIALLELIC, autosomal or pseudoautosomalInfantile nystagmus
BIALLELIC, autosomal or pseudoautosomalInherited bleeding disorders
BIALLELIC, autosomal or pseudoautosomalOcular and oculo-cutaneous albinism
BIALLELIC, autosomal or pseudoautosomalPigmentary skin disorders
BIALLELIC, autosomal or pseudoautosomalBleeding and platelet disorders
BIALLELIC, autosomal or pseudoautosomalGlaucoma (developmental)
Retinal disorders
+1 more panels — install the extension to see the full list inline on any page.
oculocutaneous albinism type 4
Abnormality of skin pigmentation
oculocutaneous albinism
oculocutaneous albinism type 6
skin neoplasm
skin cancer
hair color
cutaneous melanoma
basal cell carcinoma
skin disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Membrane-associated transporter protein
Proton-associated glucose and sucrose transporter (By similarity). May be able to transport also fructose (By similarity). Expressed at a late melanosome maturation stage where functions as proton/glucose exporter which increase lumenal pH by decreasing glycolysis (PubMed:32966160, PubMed:35469906). Regulates melanogenesis by maintaining melanosome neutralization that is initially initiated by transient OCA2 and required for a proper function of the tyrosinase TYR (PubMed:32966160, PubMed:35469906)
Curated MONDO disease pages that list SLC45A2 among their top associated genes.
SLC45A2 · Q9UMX9

Mean pLDDT
77.8/ 100
Confident
530 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0